Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Wicket Gaming’s subsidiary Wegesrand wins two international awards

Wicket Gaming's subsidiary Wegesrand's projects shine at the "International Serious Play Awards" in Toronto. "Abenteuer Hanse" wins gold in the category museum education while "Rail Experience" is awarded for its corporate/vocational skills simulations. These accolades affirm Wegesrand's global excellence in serious games and learning.Two projects from Wegesrand have now been awarded the coveted "International Serious Play Awards" at the Serious Play Conference in Toronto. The interactive museum app "Abenteuer Hanse" of The European Hanseatic Museum Lübeck won the gold medal in the category

Copenhagen municipality sees potential in Brain+’ CST-Therapist Companion to deliver Cognitive Stimulation Therapy (CST) in the municipality’s nursing homes

Copenhagen, Denmark, October 11, 2023 - Brain+ A/S (Nasdaq First North: BRAINP) · Copenhagen is also one of the Danish municipalities with the most extensive experience with CST as a treatment offer for people with dementia · Stakeholders from Copenhagen municipality have given input to the development of CST-Therapist Companion, and the product has now been through an extensive technology review with the municipality’s IT department to verify that the product lives up to their high security and quality standards · Copenhagen is the largest municipality in Denmark and has about

InDex Pharmaceuticals announces that all patients needed for the cobitolimod dose selection milestone have completed Induction Study 1 of the phase III program CONCLUDE

October 11, 2023 – InDex Pharmaceuticals Holding AB (publ) today announced that 30% of patients have completed the final visit in Induction Study 1 of the phase III program CONCLUDE, which is evaluating cobitolimod as a novel treatment for patients with moderate to severe, left-sided ulcerative colitis. The outcome of the cobitolimod dose selection analysis will be presented in Q4 this year according to plan.“We are pleased to announce that the final patient visit needed for the dose selection analysis has occurred. We have seen great progress in the study and an accelerated patient

EasyPark Group makes history with first parking apps in space

EasyPark Group, a pioneering global force in the parking technology sector, is embarking on a unique mission to welcome extraterrestrial visitors to Earth. With a history of more than 20 years of pushing innovation, EasyPark Group raises an intriguing thought: with all the UFO sightings, why haven’t we made contact yet? Could it be that aliens simply haven’t found a parking spot?In a historic first-of-its-kind effort, EasyPark Group joins forces with the Grimeton Radio station World Heritage Site to search for extraterrestrial life. The company announces that the parking apps EasyPark,

Apetit invests EUR 4.5 million in a new bottling line in the Kantvik vegetable oil milling plant

Apetit Plc, Stock Exchange Release, 11 October 2023 at 9:30 a.m.Apetit invests EUR 4.5 million in a new bottling line in the Kantvik vegetable oil milling plant Apetit is building a new bottling line for vegetable oil products in the premises of the Kantvik vegetable oil milling plant’s packing section. The value of the investment is approximately EUR 4.5 million. On the new line, vegetable oils can be bottled in plastic and glass bottles. It is estimated the new line will become operational during the second half of 2024. “Investing in a new bottling line strongly follows our

Atlas Copco’s Q3 report 2023 and invitation to the conference call, October 25

Nacka, Sweden, October 11, 2023: Atlas Copco will publish its results for Q3 2023 on Wednesday October 25[th], at approximately 12:00 CEST. A conference call for investors, analysts and media will be held at 14:00 CEST.Participating from Atlas Copco will be Mats Rahmström, President and CEO, and Peter Kinnart, CFO. The conference call will begin with a short presentation of the report followed by a question-and-answer session. If you wish to participate via webcast please use the link below. https://ir.financialhearings.com/atlas-copco-q3-report-2023 

Ericsson announces changes to the Executive Team

· Chris Houghton, currently Senior Vice President and Head of Market Area North East Asia, is appointed Chief Operating Officer. · Åsa Tamsons, currently Senior Vice President, Business Area Technologies & New Businesses, is appointed Head of Business Area Enterprise Wireless Solutions. Ericsson (NASDAQ: ERIC) today announces the appointment of Chris Houghton to Chief Operating Officer (COO) and Åsa Tamsons to Head of Business Area Enterprise Wireless Solutions. Both Mr. Houghton and Ms. Tamsons will report to Börje Ekholm, President and CEO of Ericsson. These appointments underscore

TikoMed appoints leading ALS expert Jeremy Shefner, Barrow Neurological Institute, Phoenix, Arizona to its Scientific Advisory Board (SAB)

Viken – October 11, 2023 – Swedish biopharmaceutical company TikoMed AB today announced the appointment of Professor Jeremy Shefner, MD, PhD at the Gregory W. Fulton ALS & Neuromuscular Disease Center, the Department of Neurology at Barrow Neurological Institute in Phoenix, Arizona, USA as the third member of its newly-formed Scientific Advisory Board.Professor Shefner is a neurologist focusing on biomarker development and the clinical therapeutics of amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy. He co-founded the Northeast ALS Clinical Trials Consortium (NEALS), the

SKF to publish nine-months results on 27 October

Gothenburg, 11 October 2023: SKF will publish its nine-months results for 2023 on 27 October 2023 at approximately 07:00 (CET). Investors, analysts and media are invited to join a webcast, which will be held in English, at 08:15 (CET). To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers. Link to web event: https://www.investis-live.com/skf/6511567e673c270c00dcf364/hsdt Sweden                                +46 8 5051 0031UK / International                 +44 207 107 0613Passcode:                            42753649

Risk Intelligence A/S informs about the start of subscription period and publishes memorandum

Risk Intelligence A/S ("Risk Intelligence" or the "Company”) publishes the memorandum in connection with the Company's rights issue of units where the subscription period commences today, 11 October 2023 (the "Rights Issue"). The Company raises a maximum of DKK 18.4 million and has received subscription commitments and guarantee commitments corresponding to a total of 75.2 percent of the issue volume.The memorandum, containing complete terms and conditions, will be available on the Company's website Rights Issue (riskintelligence.eu) ,

BioStock: BiBB Founder's Quest to Transform Cancer Diagnosis

Early detection of cancer plays a key role in keeping death rates low. However, today’s standard endoscopic biopsy techniques can be improved to optimise a patient’s chances. Swedish med-tech BiBBInstruments is addressing this with its motor-driven biopsy device, EndoDrill. BioStock spoke with the company’s Founder Dr Charles Walther to learn more about BiBBInstrument’s story and what inspired him to develop a new type of endoscopic biopsy instrument.Read the interview with Dr Charles Walther at biostock.se: BiBB Founder's Quest to Transform Cancer Diagnosis - BioStock 

Year-End Report 22/23

September 2022 – August 2023, Diamyd Medical AB (publ), Fiscal year 2022/2023Precision Medicine for Autoimmune Diabetes in Pivotal Phase 3Diamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com September 1, 2022 – August 31, 2023 · Operating income: MSEK 19.6 (2.6), fourth quarter: MSEK 11.2 (1.2). The increase in operating income refers mainly to milestones related to a partnership agreement with JDRF · Net result: MSEK -100.2 (-103.5), fourth quarter: MSEK -21.6 (-36.7) ·

The Board of Directors of Dustin resolves on a fully guaranteed rights issue of approximately SEK 1,750 million to reduce net debt and support continued profitable growth

THIS PRESS RELEASE IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER COUNTRY WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE PREPARED OR REGISTERED OR REQUIRE ANY OTHER ACTIONS TO BE TAKEN, IN ADDITION TO THE REQUIREMENTS UNDER SWEDISH LAW. PLEASE SEE "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE.The Board of Directors of Dustin Group AB (publ) ("Dustin"

Assemblin to participate in attractive housing project in Örebro

At the behest of Görtz Fastigheter AB, Assemblin Ventilation is to design and install all ventilation at the Fåfängan housing project in Örebro. The installation work commenced in September and will continue until the autumn of 2025. In total, the order is valued at about SEK 16.5 million.In central Örebro, a new residential block is being developed, the Fåfängan block, with 245 apartments over six to twelve floors. The buildings are designed to resemble a traditional neighbourhood around an urban square with shops at ground level. The objective is to create an attractive and cohesive

The members of the Nomination Committee for the Concentric Annual General Meeting 2024 have been appointed

The AGM 2019 has resolved that Concentric’s Nomination Committee shall have five members which consist of the Chairman of the Board and one representative of each of the four largest shareholders. The members of the Nomination Committee shall, in accordance with the resolution of the AGM 2019, be appointed based on the ownership structure as of 31st of August 2023. The members are: Monica Åsmyr, Swedbank Robur Fonder, Chairman of the Nomination Committee Maria Rengefors, Nordea Fonder Anette Dahlberg, Första AP-fonden Carl Sundblad, Cliens Fonder The Nomination Committee

Citycon once again earns double gold in EPRA awards for excellence in financial and sustainability reporting

CITYCON OYJ Corporate Press Release 11 October 2023 at 9:00 hours The European Public Real Estate Association (EPRA) has recognized Citycon's Financial Review and Sustainability Accounts for 2022 as among the best-in-class annual reports in the industry. Citycon has consistently demonstrated its commitment to excellence by securing a gold award for the integration of EPRA BPR (Best Practice Recommendation) into its financial reporting every year since 2009. Similarly, the company has maintained its gold-level status for adhering to EPRA sBPR (Sustainability Best Practice

Cloudgruppen, a company within Lyvia Group, acquires Mobile Partner

October 11[nd], 2023: Cloudgruppen Sverige AB, a company within the Lyvia sphere, has acquired Mobile Partner Sweden AB, a Swedish company specialising in comprehensive telecommunication and data communication solutions. The acquisition of Mobile Partner will add SEK 5,73 M EBITDA to the group.Cloudgruppen was founded in 2018 as an innovative company within the IT and telecom industry. With headquarters in Malmö, they have expanded geographically throughout Sweden over the last years. The acquisition of Mobile Partner is a significant enhancement to Cloudgruppen's portfolio, extending their

Wyld Networks - Long-awaited delivery started - Mangold Insight Analysis

Virtual satellite network operator Wyld Networks ("Wyld") has started to deliver modules which will generate significant cash flows moving forward.  The order book of SEK 91.5 million is starting to be converted into revenue which is a huge step forward for Wyld. Mangold believes that the most relevant aspect is how quickly Wyld can deliver the pre-ordered modules and terminals.  In the second quarter, revenue was lower than expected while costs developed at an expected rate. An agreement with SpaceX on possible areas of collaboration further demonstrate the potential of Wyld's offer. The

Presentation of Intrum’s results for July-September 2023

Intrum announces its interim results for July-September 2023 on 25 October at 7:00 a.m. CET. The report will be presented in an audiocast with teleconference at 9:00 a.m. CET the same day.At the audiocast, Intrum will be represented by Andrés Rubio, President & CEO and Michael Ladurner, CFO. The presentation will be held in English.To participate via audiocast, please use this link . Via the audiocast you will be able to ask written questions.To participate via teleconference, please register here. 

Orexo announces data from the MODIA® study evaluating impact on use of illicit opioids

· The six-month randomized controlled trial (RCT) enrolled 437 participants at 36 sites across the US · The study demonstrated no statistically significant difference between treatment arms in any pre-specified endpoint · Both treatment arms had unexpectedly high rates of treatment response, with no adverse events associated with the use of MODIA  · A post hoc analysis found that patients completing all 24 modules of MODIA had a significantly higher treatment response than those who did not complete the entire program · Orexo will continue to commercialize MODIA as a mobile

Post close trading update

FIRSTGROUP PLC post close Trading update   FirstGroup plc ('FirstGroup' or the 'Group') today provides a post close update on trading for the 27 weeks to 30 September 2023.   First Rail Demand for the division’s open access operations (Lumo and Hull Trains) has been stronger than anticipated due to increased leisure travel during the summer period. In addition, the final variable fee payments due for the division’s management fee-based contracts for the FY 2023 fiscal year have now been agreed with the Department for Transport (‘DfT’) at a rate ahead of the amounts accrued

Faron Announces Positive BEXMAB Study Update

Faron Pharmaceuticals Ltd. (“Faron” or the “Company”)   Inside information: Faron Announces Positive BEXMAB Study Update in Relapsed/Refractory AML and HMA-Refractory MDS Patients         Bexmarilimab produces a 50% remission rate in doublet dose cohorts (11 out of 22 patients)       Eight of the 11 patients are Complete Responders (CR) or CR with incomplete blood recovery (CRi)       Highest overall response rate (ORR) of 80% observed in prior HMA-failure MDS group (4 out of 5 patients)       Bexmarilimab continues to be well-tolerated with no dose-limiting

Elisa: Q3 2023 Interim Report publication on 19 October 2023

ELISA CORPORATION INVESTOR NEWS 11 OCTOBER 2023 AT 9:00 AMElisa will publish its Q3 2023 Interim Report on Thursday 19 October 2023 at approximately 8:30 am EEST.  An international conference call for analysts and investors will be held on the same day at 12:00 noon EEST. Follow the live audiocast at https://elisa.videosync.fi/q3-2023 During the conference call, questions for Elisa’s management can be presented by phone. To ask a question, please join the conference call by registering at the following link https://palvelu.flik.fi/teleconference/?id=10011162 After registering, you

Konecranes’ January-September 2023 interim report will be published on October 25, 2023

KONECRANES PLC PRESS RELEASE October 11, 2023 at 09:00 AM EEST   Konecranes’ January-September 2023 interim report will be published on October 25, 2023   Konecranes will publish its January-September 2023 interim report on Wednesday, October 25, 2023 at approximately 8:30 a.m. EEST. The report will be available on the company’s website at www.konecranes.com after publishing.   A live international webcast and telephone conference for analysts, investors and media will be arranged on the publishing day at 11:30 a.m. EEST. The event will be held in English. The interim

There are no items matching the current filter
There are no more items matching the current filter
Back to top